Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruoji Zhou

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Stem Cell Research|February 8, 2018
Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickaseJian Tu, Zijun Huo, Mo Liu, et al.
International Journal of Surgical Pathology|August 30, 2024
Renal Neoplasms with Concurrent Castleman-Like Regional LymphadenopathyAlcino Gama, Ruoji Zhou, Ivan De La Riva-Morales, et al.
The Prostate|August 18, 2024
Modern predictors and management of incidental prostate cancer at holmium enucleation of prostateEric V Li, Matthew S Lee, Jenny Guo, et al.
Stem Cell Research|January 15, 2019
Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editingZijun Huo, Jian Tu, An Xu, et al.
Cell Reports|August 8, 2019
Genomic Integrity Safeguards Self-Renewal in Embryonic Stem CellsJie Su, Dandan Zhu, Zijun Huo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2018
Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanismHuensuk Kim, Seungyeul Yoo, Ruoji Zhou, et al.
Stem Cell Research|February 8, 2018
A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editingRuoji Zhou, An Xu, Donghui Wang, et al.
The Journal of Urology|January 22, 2025
An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer TrialEric V Li, Yi Ren, Jacqueline Griffin, et al.
Stem Cell Research|October 13, 2018
Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutationBrittany E Jewell, Mo Liu, Linchao Lu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2025
Utility of <sup>18</sup>F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomyEric V Li, Edward M Schaeffer, Sai Kaushik Shankar Ramesh Kumar, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Stem Cell Research|February 8, 2018
Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickaseJian Tu, Zijun Huo, Mo Liu, et al.
International Journal of Surgical Pathology|August 30, 2024
Renal Neoplasms with Concurrent Castleman-Like Regional LymphadenopathyAlcino Gama, Ruoji Zhou, Ivan De La Riva-Morales, et al.
The Prostate|August 18, 2024
Modern predictors and management of incidental prostate cancer at holmium enucleation of prostateEric V Li, Matthew S Lee, Jenny Guo, et al.
Stem Cell Research|January 15, 2019
Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editingZijun Huo, Jian Tu, An Xu, et al.
Cell Reports|August 8, 2019
Genomic Integrity Safeguards Self-Renewal in Embryonic Stem CellsJie Su, Dandan Zhu, Zijun Huo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2018
Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanismHuensuk Kim, Seungyeul Yoo, Ruoji Zhou, et al.
Stem Cell Research|February 8, 2018
A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editingRuoji Zhou, An Xu, Donghui Wang, et al.
The Journal of Urology|January 22, 2025
An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer TrialEric V Li, Yi Ren, Jacqueline Griffin, et al.
Stem Cell Research|October 13, 2018
Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutationBrittany E Jewell, Mo Liu, Linchao Lu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2025
Utility of <sup>18</sup>F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomyEric V Li, Edward M Schaeffer, Sai Kaushik Shankar Ramesh Kumar, et al.
Pageof 3